111 related articles for article (PubMed ID: 28578024)
21. Multimeric C9 within C5b-9 is required for inner membrane damage to Escherichia coli J5 during complement killing.
Bloch EF; Schmetz MA; Foulds J; Hammer CH; Frank MM; Joiner KA
J Immunol; 1987 Feb; 138(3):842-8. PubMed ID: 3100618
[TBL] [Abstract][Full Text] [Related]
22. Complement activation on B lymphocytes opsonized with rituximab or ofatumumab produces substantial changes in membrane structure preceding cell lysis.
Beum PV; Lindorfer MA; Beurskens F; Stukenberg PT; Lokhorst HM; Pawluczkowycz AW; Parren PW; van de Winkel JG; Taylor RP
J Immunol; 2008 Jul; 181(1):822-32. PubMed ID: 18566448
[TBL] [Abstract][Full Text] [Related]
23. Cooperation between Hsp90 and mortalin/GRP75 in resistance to cell death induced by complement C5b-9.
Rozenberg P; Ziporen L; Gancz D; Saar-Ray M; Fishelson Z
Cell Death Dis; 2018 Feb; 9(2):150. PubMed ID: 29396434
[TBL] [Abstract][Full Text] [Related]
24. Membrane attack complex of complement in dermatitis herpetiformis.
Dahl MV; Falk RJ; Carpenter R; Michael AF
Arch Dermatol; 1985 Jan; 121(1):70-2. PubMed ID: 3881089
[TBL] [Abstract][Full Text] [Related]
25. Construction and characterization of recombinant human C9 or C7 linked to single chain Fv directed to CD25.
Raitses Gurevich M; Fishelson Z
Mol Immunol; 2013 Oct; 55(3-4):400-8. PubMed ID: 23582305
[TBL] [Abstract][Full Text] [Related]
26. Enhanced CDC of B cell chronic lymphocytic leukemia cells mediated by rituximab combined with a novel anti-complement factor H antibody.
Winkler MT; Bushey RT; Gottlin EB; Campa MJ; Guadalupe ES; Volkheimer AD; Weinberg JB; Patz EF
PLoS One; 2017; 12(6):e0179841. PubMed ID: 28658265
[TBL] [Abstract][Full Text] [Related]
27. Human protectin (CD59), an 18,000-20,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers.
Meri S; Morgan BP; Davies A; Daniels RH; Olavesen MG; Waldmann H; Lachmann PJ
Immunology; 1990 Sep; 71(1):1-9. PubMed ID: 1698710
[TBL] [Abstract][Full Text] [Related]
28. The relationship between channel size and the number of C9 molecules in the C5b-9 complex.
Ramm LE; Whitlow MB; Mayer MM
J Immunol; 1985 Apr; 134(4):2594-9. PubMed ID: 2579147
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of C9 polymerization within the SC5b-9 complex of complement by S-protein.
Podack ER; Preissner KT; Müller-Eberhard HJ
Acta Pathol Microbiol Immunol Scand Suppl; 1984; 284():89-96. PubMed ID: 6587746
[TBL] [Abstract][Full Text] [Related]
30. C9-mediated killing of bacterial cells by transferred C5b-8 complexes: transferred C5b-9 complexes are nonbactericidal.
Blanchard KP; Dankert JR
Infect Immun; 1994 Oct; 62(10):4101-6. PubMed ID: 7927662
[TBL] [Abstract][Full Text] [Related]
31. The membrane attack complex of complement: C5b-8 complex as accelerator of C9 polymerization.
Tschopp J; Podack ER; Müller-Eberhard HJ
J Immunol; 1985 Jan; 134(1):495-9. PubMed ID: 3964819
[TBL] [Abstract][Full Text] [Related]
32. C5b-9 assembly: average binding of one C9 molecule to C5b-8 without poly-C9 formation generates a stable transmembrane pore.
Bhakdi S; Tranum-Jensen J
J Immunol; 1986 Apr; 136(8):2999-3005. PubMed ID: 3958488
[TBL] [Abstract][Full Text] [Related]
33. Polymerization of C9 enhances bacterial cell envelope damage and killing by membrane attack complex pores.
Doorduijn DJ; Heesterbeek DAC; Ruyken M; de Haas CJC; Stapels DAC; Aerts PC; Rooijakkers SHM; Bardoel BW
PLoS Pathog; 2021 Nov; 17(11):e1010051. PubMed ID: 34752492
[TBL] [Abstract][Full Text] [Related]
34. Transmembrane channel-formation by five complement proteins.
Müller-Eberhard HJ
Biochem Soc Symp; 1985; 50():235-46. PubMed ID: 2428370
[TBL] [Abstract][Full Text] [Related]
35. Resistance of Escherichia coli to osmotically introduced complement component C9.
Dankert JR
Infect Immun; 1991 Jan; 59(1):109-13. PubMed ID: 1987022
[TBL] [Abstract][Full Text] [Related]
36. Interactions of soluble CD59 with the terminal complement complexes. CD59 and C9 compete for a nascent epitope on C8.
Lehto T; Meri S
J Immunol; 1993 Nov; 151(9):4941-9. PubMed ID: 7691959
[TBL] [Abstract][Full Text] [Related]
37. Recurrent meningitis in a patient with congenital deficiency of the C9 component of complement. First case of C9 deficiency in Europe.
Zoppi M; Weiss M; Nydegger UE; Hess T; Späth PJ
Arch Intern Med; 1990 Nov; 150(11):2395-9. PubMed ID: 2241452
[TBL] [Abstract][Full Text] [Related]
38. The role of C9 in complement-mediated killing of Neisseria.
Harriman GR; Esser AF; Podack ER; Wunderlich AC; Braude AI; Lint TF; Curd JG
J Immunol; 1981 Dec; 127(6):2386-90. PubMed ID: 6795273
[TBL] [Abstract][Full Text] [Related]
39. The relationship between polymerization of complement component C9 and membrane channel formation.
DiScipio RG
J Immunol; 1991 Dec; 147(12):4239-47. PubMed ID: 1721643
[TBL] [Abstract][Full Text] [Related]
40. Extracellular phosphorylation of C9 by protein kinase CK2 regulates complement-mediated lysis.
Bohana-Kashtan O; Pinna LA; Fishelson Z
Eur J Immunol; 2005 Jun; 35(6):1939-48. PubMed ID: 15902683
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
